StonvexLoading…
StonvexStonvexStonvexCore line items from IREN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 |
|---|---|---|---|
Revenue | $501.02M | $187.19M | $75.51M |
Operating Income | $17.33M | $-27.23M | $-157.24M |
Net Income | $86.94M | $-28.92M | $-171.83M |
EPS (Diluted) | $0.39 | $-0.29 | $-3.14 |
Total Assets | $2.94B | $1.15B | $332.07M |
Total Liabilities | $1.12B | $55.35M | $26.71M |
Cash & Equivalents | $564.53M | $404.60M | $68.89M |
Free Cash Flow OCF − CapEx | $-327.57M | $-89.64M | $-110.33M |
Shares Outstanding | 223.25M | 99.64M | 54.78M |